Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...

Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs.

I was six years old when my sister was born, and I remember it vividly. In the hospital nursery, I saw rows of tiny newborns and nurses moving between isolettes with practiced precision. The moment ...

Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU ...

In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist ...

Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST ...

Typically, software placed on the market will undergo changes and updates after its initial release. In the case of ...

Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and ...

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical ...

Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding ...

The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its ...